Finger, Robert P.
Daien, Vincent
Eldem, Bora M.
Talks, James S.
Korobelnik, Jean-Francois
Mitchell, Paul
Sakamoto, Taiji
Wong, Tien Yin
Pantiri, Krystallia
Carrasco, Joao
Funding for this research was provided by:
Bayer
Article History
Received: 7 February 2020
Accepted: 6 July 2020
First Online: 17 July 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: The following authors report consulting fees, travel support, and financial and non-financial support outside the submitted work: R. P. Finger – Bayer, Novartis, Novelion, Opthea, RetinaImplant, and Santen; V. Daien – Alcon, Bayer, Horus, Novartis, and Thea; B. M. Eldem – Alcon, Allergan Novartis, Bayer, Bausch & Lomb, Ophtotech, Pfizer, Roche, Sanofi, Santen, Servier, and Thea; J. S. Talks – Allergan, Bayer, and Novartis; J.-F. Korobelnik – Alcon, Bayer, Bausch & Lomb, Beaver-Visitec, Krys, Kanghing, Nano Retina, Novartis, Roche, Thea, and Zeiss; P. Mitchell – Abbott, Allergan, Bayer, Genentech, Novartis, and Roche; T. Sakamoto: Alcon, Bayer, Novartis, Santen, Senju, and Wakamoto; T. Y. Wong – Abbott, Allergan, Bayer, Novartis, Pfizer, and Roche.K. Pantiri is an employee of Pharmerit International.J. Carrasco is an employee of Bayer Consumer Care AG.